Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05ZDQ
|
||||
Former ID |
DNC013707
|
||||
Drug Name |
1-(2-hydroxyphenyl)-3-p-tolylprop-2-en-1-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529976] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H14O2
|
||||
Canonical SMILES |
CC1=CC=C(C=C1)C=CC(=O)C2=CC=CC=C2O
|
||||
InChI |
1S/C16H14O2/c1-12-6-8-13(9-7-12)10-11-16(18)14-4-2-3-5-15(14)17/h2-11,17H,1H3/b11-10+
|
||||
InChIKey |
OOEWKJHFFYCQBM-ZHACJKMWSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Prostaglandin G/H synthase 2 | Target Info | Inhibitor | [529976] | |
KEGG Pathway | Arachidonic acid metabolism | ||||
Metabolic pathways | |||||
NF-kappa B signaling pathway | |||||
VEGF signaling pathway | |||||
TNF signaling pathway | |||||
Retrograde endocannabinoid signaling | |||||
Serotonergic synapse | |||||
Ovarian steroidogenesis | |||||
Oxytocin signaling pathway | |||||
Regulation of lipolysis in adipocytes | |||||
Leishmaniasis | |||||
Pathways in cancer | |||||
Chemical carcinogenesis | |||||
MicroRNAs in cancer | |||||
Small cell lung cancer | |||||
PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.